These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 17631178

  • 1. Hematopoietic growth factors in the treatment of acquired bone marrow failure states.
    Marsh JC, Ganser A, Stadler M.
    Semin Hematol; 2007 Jul; 44(3):138-47. PubMed ID: 17631178
    [Abstract] [Full Text] [Related]

  • 2. Haemopoietic growth factors in myelodysplastic syndromes: towards patient-oriented therapy?
    Clavio M, Balleari E, Garrone A, Ballerini F, Varaldo R, Michelis GL, Balocco M, Abdall N, Colombo N, Grasso R, Gobbi M.
    J Exp Clin Cancer Res; 2005 Mar; 24(1):5-16. PubMed ID: 15943026
    [Abstract] [Full Text] [Related]

  • 3. [Hematopoietic growth factors in prophylaxis and therapy of infections complications in children with neutropenia].
    Lehrnbecher T.
    Klin Padiatr; 2001 Mar; 213(4):212-38. PubMed ID: 11528556
    [Abstract] [Full Text] [Related]

  • 4. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P, Sanpaolo G, D'Arena G, Scalzulli PR, Matera R, Falcone A, Bodenizza C, Perla G, Carotenuto M.
    Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
    [Abstract] [Full Text] [Related]

  • 5. The use of haemopoietic growth factors in the treatment of myelodysplastic syndromes.
    Greenberg PL, Negrin R, Nagler A.
    Cancer Surv; 1990 Jan; 9(1):199-212. PubMed ID: 2276114
    [Abstract] [Full Text] [Related]

  • 6. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
    Balleari E, Rossi E, Clavio M, Congiu A, Gobbi M, Grosso M, Secondo V, Spriano M, Timitilli S, Ghio R.
    Ann Hematol; 2006 Mar; 85(3):174-80. PubMed ID: 16408206
    [Abstract] [Full Text] [Related]

  • 7. Special Education: Aplastic Anemia.
    Teramura M, Mizoguchi H.
    Oncologist; 1996 Mar; 1(3):187-189. PubMed ID: 10387986
    [Abstract] [Full Text] [Related]

  • 8. Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses.
    Wu HH, Talpaz M, Champlin RE, Pilat SR, Kurzrock R.
    Cancer; 2003 Dec 01; 98(11):2410-9. PubMed ID: 14635076
    [Abstract] [Full Text] [Related]

  • 9. Treatment with growth factors in myelodysplastic syndromes.
    Geissler RG, Schulte P, Ganser A.
    Pathol Biol (Paris); 1997 Oct 01; 45(8):656-67. PubMed ID: 9569932
    [Abstract] [Full Text] [Related]

  • 10. Hematopoietic growth factors in myelodysplastic syndromes.
    Blinder VS, Roboz GJ.
    Curr Hematol Rep; 2003 Nov 01; 2(6):453-8. PubMed ID: 14561388
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes.
    Hellström-Lindberg E, Malcovati L.
    Semin Hematol; 2008 Jan 01; 45(1):14-22. PubMed ID: 18179965
    [Abstract] [Full Text] [Related]

  • 15. Use of hematopoietic growth factors for treatment of aplastic anemia.
    Kojima S.
    Bone Marrow Transplant; 1996 Dec 01; 18 Suppl 3():S36-8. PubMed ID: 8971406
    [Abstract] [Full Text] [Related]

  • 16. Haematopoietic growth factors in the treatment of myelodysplastic syndromes.
    Cazzola M.
    Forum (Genova); 1999 Dec 01; 9(1):49-57. PubMed ID: 10101210
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Recombinant human granulocyte-macrophage colony-stimulating factor plus erythropoietin for the treatment of cytopenias in patients with myelodysplastic syndromes.
    Stasi R, Pagano A, Terzoli E, Amadori S.
    Br J Haematol; 1999 Apr 01; 105(1):141-8. PubMed ID: 10233377
    [Abstract] [Full Text] [Related]

  • 20. Supportive care including growth factors in myelodysplastic syndromes.
    Gardin C, Fenaux P.
    Rev Clin Exp Hematol; 2004 Dec 01; 8(2):E3. PubMed ID: 16027101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.